| |
| |
|
| Insider
Information: |
Lanchbury Jerry S |
| Relationship: |
Chief Scientific Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
264,324 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,132,317 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
264,324 |
|
|
| Total
Value |
$6,132,317 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-09-17 |
4 |
AS |
$28.00 |
$140,000 |
D/D |
(5,000) |
17,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-02-01 |
4 |
D |
$24.15 |
$144,924 |
D/D |
(6,000) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-08-09 |
4 |
OE |
$14.81 |
$148,100 |
D/D |
10,000 |
100 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-09-27 |
4 |
OE |
$14.81 |
$148,633 |
D/D |
10,036 |
380 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-03 |
4 |
OE |
$16.64 |
$166,400 |
D/D |
10,000 |
28,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-03-26 |
4 |
OE |
$8.49 |
$169,700 |
D/D |
20,000 |
61,428 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-01-11 |
4 |
AS |
$34.00 |
$170,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-12-03 |
4 |
OE |
$8.63 |
$172,600 |
D/D |
20,000 |
37,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-06-28 |
4 |
OE |
$19.47 |
$173,795 |
D/D |
6,812 |
233,498 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2008-12-18 |
4 |
OE |
$16.97 |
$187,650 |
D/D |
10,000 |
18,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-02-01 |
4 |
OE |
$8.63 |
$188,169 |
D/D |
21,804 |
44,539 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-10-26 |
4 |
OE |
$16.53 |
$189,946 |
D/D |
11,491 |
82,228 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-02-06 |
4 |
OE |
$20.56 |
$216,659 |
D/D |
10,000 |
25,303 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-06-28 |
4 |
AS |
$32.23 |
$220,608 |
D/D |
(6,812) |
232,550 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-08-07 |
4 |
OE |
$14.81 |
$222,150 |
D/D |
15,000 |
6,000 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2017-09-17 |
4 |
D |
$33.05 |
$227,946 |
D/D |
(6,897) |
150,137 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-11-06 |
4 |
OE |
$7.82 |
$233,677 |
D/D |
29,882 |
34,517 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-10-27 |
4 |
OE |
$16.53 |
$236,157 |
D/D |
12,336 |
75,775 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-03-15 |
4 |
OE |
$9.04 |
$239,885 |
D/D |
26,536 |
49,271 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-25 |
4 |
D |
$46.65 |
$258,628 |
D/D |
(5,544) |
176,750 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-09-17 |
4 |
D |
$41.39 |
$285,467 |
D/D |
(6,897) |
70,737 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2019-09-25 |
4 |
D |
$29.93 |
$292,057 |
D/D |
(9,758) |
194,141 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-17 |
4 |
D |
$46.35 |
$301,970 |
D/D |
(6,515) |
132,294 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2019-09-30 |
4 |
D |
$28.63 |
$306,370 |
D/D |
(10,701) |
183,440 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2011-05-18 |
4 |
OE |
$6.00 |
$307,235 |
D/D |
44,314 |
34,201 |
0 |
- |
|
140 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
